Because the world of AIDS research and punditry is dominated by a small clique of powerful individuals (the vast majority of whom haven't followed a patient in years and are lavishly pampered and subsidized by the marketers of AIDS meds), less drug intensive approaches to treating HIV are ignored, sidelined or sabotaged. Treatment protocols which used fewer drugs would cost the pharmaceutical industry billions of dollars in lost sales and are skillfully marginalized.